Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23423576 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown 
Has Results
Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: mAb hOKT3gamma1(Ala-Ala), Teplizumab;   Drug: Placebo Arm

Indicates status has not been verified in more than two years